Bristol-Myers Squibb's Kidney Opportunity Is Bigger Than Some Thought
September 22, 2015 at 14:48 PM EDT
In a report issued Tuesday, Morgan Stanley analyst David Risinger and his team reiterated an Overweight rating on Bristol-Myers ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.